Literature DB >> 8591918

Binocular luminance summation in humans with defective binocular vision.

R Sireteanu1.   

Abstract

Subjects with no functional binocularity (no stereopsis and no peripheral fusion) show much less binocular summation of the pupillary response (about 12%) than normal subjects (29%). However, summation is occasionally quite high in clinically stereoblind subjects. The reasons could be the simultaneous use of nonoverlapping fields of the two eyes in large-angle exotropes, peripheral fusion (common in microstrabismus), a mosaic of inputs from the two eyes in different parts of the visual field (often seen in strabismic alternators), or the incomplete suppression of the deviated eye in subjects with double images. These results suggest that the binocular summation of the pupillary response can be used as a test for the simultaneous use of the two eyes, rather than as an index of functional binocularity and stereopsis.

Entities:  

Mesh:

Year:  1987        PMID: 8591918

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Binocular contrast summation and inhibition in amblyopia. The influence of the interocular difference on binocular contrast sensitivity.

Authors:  S Pardhan; J Gilchrist
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  Quadrantal macular retinal thickness changes in strabismus subjects with abnormal binocular vision development.

Authors:  Mayumi Oka; Tsutomu Yamashita; Shizuka Ono; Ikumi Kubo; Akio Tabuchi
Journal:  Jpn J Ophthalmol       Date:  2012-11-28       Impact factor: 2.447

3.  Relationship Between Binocular Summation and Stereoacuity After Strabismus Surgery.

Authors:  Jaffer M Kattan; Federico G Velez; Joseph L Demer; Stacy L Pineles
Journal:  Am J Ophthalmol       Date:  2016-02-26       Impact factor: 5.258

4.  Pupil responses to near visual demand during human visual development.

Authors:  Shrikant R Bharadwaj; Jingyun Wang; T Rowan Candy
Journal:  J Vis       Date:  2011-04-11       Impact factor: 2.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.